Related Experiment Video
Updated: Aug 10, 2026

08:51
Human Egg Maturity Assessment and Its Clinical Application
Published on: August 19, 2019
Prospects for oocyte banking and in vitro maturation
1Center for Reproductive Medicine and Infertility, Weill Medical College, Cornell University, 505 East 70 Street (HT340), New York, NY 10021, USA. rgg2004@med.cornell.edu
Journal of the National Cancer Institute. Monographs
|March 24, 2005
Summary
Human egg banking offers fertility preservation for cancer patients but faces inefficiencies. Ongoing research into vitrification and immature oocyte cryopreservation aims to improve success rates for future fertility options.
Area of Science:
- Reproductive biology
- Cryopreservation technologies
- Oncofertility
Background:
- Human oocyte (egg) banking is crucial for fertility preservation in young cancer patients undergoing sterilizing treatments.
- It presents a desirable alternative to in vitro fertilization and embryo cryopreservation.
Purpose of the Study:
- To evaluate the current prospects and challenges of human oocyte banking.
- To explore innovative cryopreservation techniques for improving oocyte survival and pregnancy rates.
Main Methods:
- Review of existing literature on oocyte cryopreservation techniques, including conventional cooling and vitrification.
- Analysis of methods involving freezing immature oocytes followed by in vitro maturation.
- Assessment of factors affecting oocyte survival, such as chilling sensitivity, freeze-thawing damage, and aneuploidy.
Main Results:
- Current oocyte banking methods are inefficient, with low survival rates after freeze-thawing and potential for cytoskeletal damage and aneuploidy.
- Optimistic success rates with current technologies offer patients a limited chance of pregnancy, especially with few oocytes.
- Vitrification and in vitro maturation of immature oocytes show promise but require further investigation and improvement.
Conclusions:
- Despite current inefficiencies, advancements in cryopreservation technologies are enhancing the prospects of human oocyte banking.
- Further research into ultra-rapid freezing (vitrification) and immature oocyte cryopreservation is essential.
- Oocyte banking is expected to become a more viable fertility preservation option for patients in the future.
Related Concept Videos
Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

